Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1693 to 1742 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 2 (ec 1.1.1.205) (imp dehydrogenase 2) (impdh-ii) (impd 2). [source:swissprot;acc:p12268]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.937\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.971\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01373\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gmp synthase [glutamine-hydrolyzing] (ec 6.3.5.2) (glutamine amidotransferase) (gmp synthetase). [source:swissprot;acc:p49915]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 1 (ec 1.1.1.205) (imp dehydrogenase 1) (impdh-i) (impd 1). [source:swissprot;acc:p20839]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.624\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.69\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01367\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucose-6-phosphate 1-dehydrogenase (ec 1.1.1.49) (g6pd). [source:swissprot;acc:p11413]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
216.079\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.024\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01363\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-repair protein xrcc3 (x-ray repair cross-complementing protein 3). [source:swissprot;acc:o43542]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase q5 (recq protein-like 5) (recq5). [source:swissprot;acc:o94762]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2-binding protein. [source:swissprot;acc:q9nwb1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.514\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.577\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01362\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 4 (ec 3.1.3.16) (pp4) (protein phosphatase x) (pp-x). [source:swissprot;acc:p33172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
223.846\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.847\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01358\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.283\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.334\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01351\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1708\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein prh (hematopoietically expressed homeobox) (homeobox protein hex). [source:swissprot;acc:q03014]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.385\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01346\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.225\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01345\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
biotin--protein ligase (ec 6.3.4.-) (biotin apo-protein ligase) [includes: biotin--[methylmalonyl-coa-carboxyltransferase] ligase (ec 6.3.4.9); biotin--[propionyl-coa-carboxylase [atp-hydrolyzing]] ligase (ec 6.3.4.10) (holocarboxylase synthetase) (hcs); biotin--[methylcrotonoyl-coa-carboxylase] ligase (ec 6.3.4.11); biotin--[acetyl-coa-carboxylase] ligase (ec 6.3.4.15)]. [source:swissprot;acc:p50747]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.436\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.553\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 28 kda subunit (tafii-28) (tafii28) (tfiid subunit p30-beta). [source:swissprot;acc:q15544]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.598\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.375\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01331\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 3 (sh3 domain protein 2c) (een-b2). [source:swissprot;acc:q99963]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.823\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.111\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
206.549\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
203.844\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01327\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 2 (sh3 domain protein 2a) (endophilin 1) (een-b1). [source:swissprot;acc:q99962]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.522\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.818\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
o-sialoglycoprotein endopeptidase. [source:refseq;acc:nm\_017807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.058\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.164\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.251\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.553\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
helicase (fragment). [source:sptrembl;acc:q92771]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.204\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
189.679\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01322\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead/h (asp-glu-ala-asp/his) box polypeptide 11; dead/h box-11 (chl1-related helicase gene-1); yeast chl1 homolog. [source:refseq;acc:nm\_030655]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.205\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.125\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s13. [source:swissprot;acc:q02546]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.899\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.813\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01319\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative inorganic polyphosphate/atp-nad kinase (ec 2.7.1.23) (poly(p)/atp nad kinase). [source:swissprot;acc:o95544]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.147\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate multikinase. [source:refseq;acc:nm\_152230]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.676\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.53\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01311\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
afg3-like protein 2 (ec 3.4.24.-) (paraplegin-like protein). [source:swissprot;acc:q9y4w6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-(1,6)-fucosyltransferase (ec 2.4.1.68) (glycoprotein 6-alpha-l- fucosyltransferase) (gdp-fucose--glycoprotein fucosyltransferase) (gdp-l-fuc:n-acetyl-beta-d-glucosaminide alpha1,6-fucosyltransferase) (alpha1-6fuct) (fucosyltransferase 8). [source:swissprot;acc:q9byc5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.358\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.103\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01305\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.582\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chaperone-activity of bc1 complex-like, mitochondrial precursor (chaperone-abc1-like). [source:swissprot;acc:q8ni60]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.336\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.567\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 2; putative ubiquinone biosynthesis protein aarf. [source:refseq;acc:nm\_052853]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 4. [source:refseq;acc:nm\_024876]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 1. [source:refseq;acc:nm\_020421]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucyl-trna synthetase. [source:refseq;acc:nm\_020117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipoate-protein ligase, mitochondrial precursor (ec 6.-.-.-) (lipoate biosynthesis protein) (lipoyl ligase) (lipoyltransferase). [source:swissprot;acc:q9y234]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
206.595\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.258\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin gamma-1 chain (gamma-1 tubulin) (gamma-tubulin complex component 1) (gcp-1). [source:swissprot;acc:p23258]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
defender against cell death 1 (dad-1). [source:swissprot;acc:p46966]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex 11. [source:refseq;acc:nm\_018679]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin gamma-2 chain (gamma-2 tubulin). [source:swissprot;acc:q9nrh3]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/